Module

Adjuvant Treatment for Rectal Cancer

Source: Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups

Adjuvant Treatment for Rectal Cancer

Faculty:

Joel E. Tepper, MD

CME CREDIT INFORMATION

Release Date: 09/04/07

Expiration Date: 09/03/08

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.8 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe outcomes from different surgical techniques used for resection of early-stage rectal cancer
Recall important unanswered questions in the adjuvant treatment of rectal cancer
List current clinical trials for patients with rectal cancer
Summarize recent clinical data regarding the use of targeted biologic therapy in the setting of rectal cancer

Topics covered include:

Introduction
Surgery
Radiation Therapy
Neoadjuvant Chemotherapy and Biologics
Targeted Agents
Unanswered Questions in the Adjuvant Treatment of Rectal Cancer
Currently Open Trials in Rectal Cancer
Priority Issues in Colorectal Cancer: Adjuvant Treatment for Rectal Cancer

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.